Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

methionine restriction

  • Open Access
    Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo
    YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo March 2026, 40 (2) 803-812; DOI: https://doi.org/10.21873/invivo.14238
  • Open Access
    HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice
    SEI MORINAGA, KOHEI MIZUTA, BYUNG MO KANG, QINGHONG HAN, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo May 2025, 39 (3) 1275-1282; DOI: https://doi.org/10.21873/invivo.13931
  • Open Access
    HT1080 Fibrosarcoma With Acquired Trabectedin Resistance: Increased Malignancy But Sustained Sensitivity to Methionine Restriction
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo March 2025, 39 (2) 683-690; DOI: https://doi.org/10.21873/invivo.13872
  • Open Access
    Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    In Vivo January 2025, 39 (1) 120-126; DOI: https://doi.org/10.21873/invivo.13809
  • Open Access
    Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
    MOTOKAZU SATO, QINGHONG HAN, KOHEI MIZUTA, RYOSUKE MORI, BYUNG MO KANG, SEI MORINAGA, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    In Vivo May 2024, 38 (3) 1459-1464; DOI: https://doi.org/10.21873/invivo.13591
  • Open Access
    Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model
    MOTOKAZU SATO, KOHEI MIZUTA, QINGHONG HAN, SEI MORINAGA, BYUNG MO KANG, YUTARO KUBOTA, RYOSUKE MORI, ANTON BARANOV, KEITA KOBAYASHI, DANIEL ARDJMAND, NORITOSHI KOBAYASHI, MICHAEL BOUVET, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    In Vivo May 2024, 38 (3) 1058-1063; DOI: https://doi.org/10.21873/invivo.13539
  • Open Access
    Methionine Dependence of Hair Maintenance in C57BL/6 Mice
    YUTARO KUBOTA, NUNDINI VARSHNEY, KEITA KOBAYASHI, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo May 2024, 38 (3) 1199-1202; DOI: https://doi.org/10.21873/invivo.13555
  • Open Access
    [11C] Methionine-PET Imaging as a Cancer Biomarker for Methionine Addiction and Sensitivity to Methionine-restriction-based Combination Chemotherapy
    YUTARO KUBOTA, TOSHIHIKO SATO, QINGHONG HAN, CHIHIRO HOZUMI, SEI MORINAGA, KOHEI MIZUTA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo January 2024, 38 (1) 253-258; DOI: https://doi.org/10.21873/invivo.13432
  • Open Access
    Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
    YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
  • You have access
    Oral Methioninase for Covid-19 Methionine-restriction Therapy
    ROBERT M. HOFFMAN and QINGHONG HAN
    In Vivo June 2020, 34 (3 suppl) 1593-1596; DOI: https://doi.org/10.21873/invivo.11948

Pages

  • Next
  • 1
  • 2
In Vivo

© 2026 In Vivo

Powered by HighWire